Angiopoietin-2 is implicated in the regulation of tumor angiogenesis

American Journal of Pathology

Volumn 158, Issue 2, 2001, Pages 563-570

  Yu, Q ^a   Stamenkovic, I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CONTROLLED STUDY; HISTOPATHOLOGY; LUNG CARCINOMA; MALE; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 0035134082     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63998-3     Document Type: Article

References (32)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. How does extracellular matrix control capillary morphogenesis?
3. Differentiation of endothelium
4. Patterns and emerging mechanism of the angiogenic switch during tumorigenesis
5. Mechanism of angiogenesis
6. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development
7. Endothelial receptor tyrosine kinases involved in angiogenesis
8. Role of the Fit-1 receptor tyrosine kinase in regulating assembly of vascular endothelium
9. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
10. Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in epithelial cells, and their presumptive precursors
11. Tie-1 and tie-2 define a new class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system
12. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage
13. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
14. Distinct roles of the receptor tyrosine kinase Tie-1 and Tie-2 in blood vessel formation
15. Requisite role of angiopoietin-1, a ligand for the tie2 receptor, during embryonic angiogenesis
16. Tie2 expression, and phosphorylation in angiogenic, and quiescent adult tissues
17. Expression of Tie2/Tek in breast tumor vasculature provides a new marker for evaluation of tumor angiogenesis
18. Cell-type specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
19. Isolation of angiopoietin-1, a ligand for the tie2 receptor, by secretiontrap expression cloning
20. Angiopoietin-2, a natural antagonist for Tie 2 that disrupts in vivo angiogenesis
21. Vascular endothelial growth factor is a secreted angiogenic mitogen
22. Isolation and characterization of a new identified endothelial cell mitogen produced by AtT20 cells
23. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
24. Angiopoietin-1 induces sprouting angiogenesis in vitro
25. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie 2
26. Is angiopoietin-2 necessary for thee initiation of tumor angiogenesis?
27. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
28. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function
29. Pericyte physiology
30. Angiopoietin-1 inhibits endothelial cell apoptosis via Akt/Survivin pathway
31. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway
32. Pieces of eight: Bioactive fragments of extracellular proteins as regulator of angiogenesis